Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
New product
Subject category: Marketing
Published by: China Europe International Business School
Originally published in: 2023
Version: 2023-06-13
Length: 19 pages
Data source: Field research

Abstract

The sales of various drug products for AstraZeneca, a multinational pharmaceutical company, have been greatly impacted by the volume-based procurement resulting from the medical reform in China. Meanwhile, the Covid-19 epidemic has catapulted the internet pharmaceutical industry into rapid development. When crises are intermingled with opportunities, AstraZeneca attempted to establish Yiliyili.com, an internet medical service platform, by leveraging its offline resources. Chen Hua, the CEO of Yiliyili.com, has 14 years of experience in pharmaceutical e-Commerce and has set up an innovative 'doctors-to-pharmaceuticals' model in contrast to the mainstream that runs otherwise. This model was created through collaboration with doctors from contracted offline hospitals who were engaged online. The goal was to establish a stable and active group of doctor users while providing them with empowerment and supporting services. The objective was to replicate existing doctor-patient relationships in an online setting. Meanwhile, it has extended services in physical medical and pharmaceutical products to value-additive services such as case management and compliance-related services for patients. It has also extended the provision of prescription drugs other than essential drugs at non-public offline hospitals according to patients' needs to enhance its marketing abilities for such drugs. Furthermore, it has used its marketing capacity for prescription drugs to establish cooperation with other medical appliance manufacturers to form an integrated marketing platform through which it could average down its fixed costs for maintaining a huge marketing team while better-utilizing marketing capacities. Can Yiliyili.com gain a competitive edge over its traditional competitors by implementing a service-heavy strategy and utilizing its offline strengths to outperform its online advantages? Will it be able to establish itself as a top-notch provider of exceptional and cost-effective services amidst the Internet hospital construction boom?

Teaching and learning

This item is suitable for postgraduate and executive education courses.

Geographical setting

Region:
Asia
Country:
China

Featured companies

AstraZeneca Investment (China) Co, Ltd
GL Ventures
Hainan Yili Health Technology Co., Ltd.

Featured protagonist

  • Chen Hua (male), CEO

About

Abstract

The sales of various drug products for AstraZeneca, a multinational pharmaceutical company, have been greatly impacted by the volume-based procurement resulting from the medical reform in China. Meanwhile, the Covid-19 epidemic has catapulted the internet pharmaceutical industry into rapid development. When crises are intermingled with opportunities, AstraZeneca attempted to establish Yiliyili.com, an internet medical service platform, by leveraging its offline resources. Chen Hua, the CEO of Yiliyili.com, has 14 years of experience in pharmaceutical e-Commerce and has set up an innovative 'doctors-to-pharmaceuticals' model in contrast to the mainstream that runs otherwise. This model was created through collaboration with doctors from contracted offline hospitals who were engaged online. The goal was to establish a stable and active group of doctor users while providing them with empowerment and supporting services. The objective was to replicate existing doctor-patient relationships in an online setting. Meanwhile, it has extended services in physical medical and pharmaceutical products to value-additive services such as case management and compliance-related services for patients. It has also extended the provision of prescription drugs other than essential drugs at non-public offline hospitals according to patients' needs to enhance its marketing abilities for such drugs. Furthermore, it has used its marketing capacity for prescription drugs to establish cooperation with other medical appliance manufacturers to form an integrated marketing platform through which it could average down its fixed costs for maintaining a huge marketing team while better-utilizing marketing capacities. Can Yiliyili.com gain a competitive edge over its traditional competitors by implementing a service-heavy strategy and utilizing its offline strengths to outperform its online advantages? Will it be able to establish itself as a top-notch provider of exceptional and cost-effective services amidst the Internet hospital construction boom?

Teaching and learning

This item is suitable for postgraduate and executive education courses.

Settings

Geographical setting

Region:
Asia
Country:
China

Featured companies

AstraZeneca Investment (China) Co, Ltd
GL Ventures
Hainan Yili Health Technology Co., Ltd.

Featured protagonist

  • Chen Hua (male), CEO

Related